Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 23, Issue 9

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 23, Issue 9 (2014)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 23, Issue 9 (2014)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Volume 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Reviews

Review Article

NMDA antagonists under investigation for the treatment of major depressive disorder

Bartłomiej Pochwat, Agnieszka Pałucha-Poniewiera, Bernadeta Szewczyk, Andrzej Pilc & Gabriel Nowak

Pages: 1181-1192

Published online: 12 May 2014

AbstractforNMDA antagonists under investigation for the treatment of major depressive disorder | Full Text | References | PDF (591.9 KB)

1198 Views
32 CrossRef citations
0Altmetric

Review Article

Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma

Sara Bringhen MD, Francesca Gay MD, Francesca Donato MD, Rossella Troia, Roberto Mina MD & Antonio Palumbo MD

Pages: 1193-1209

Published online: 06 Jun 2014

AbstractforCurrent Phase II investigational proteasome inhibitors for the treatment of multiple myeloma | Full Text | References | PDF (481.3 KB)

437 Views
4 CrossRef citations
0Altmetric

Review Article

Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus

Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo & Guglielmo Borgia MD

Pages: 1211-1223

Published online: 21 May 2014

AbstractforInvestigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus | Full Text | References | PDF (305 KB)

386 Views
29 CrossRef citations
0Altmetric

Review Article

Therapeutical approaches under investigation for treatment of Chagas disease

Maria Terezinha Bahia, Lívia de Figueiredo Diniz & Vanessa Carla Furtado Mosqueira

Pages: 1225-1237

Published online: 26 May 2014

AbstractforTherapeutical approaches under investigation for treatment of Chagas disease | Full Text | References | PDF (499.7 KB)

563 Views
52 CrossRef citations
0Altmetric

Review Article

An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis

Laura Obici MD & Giampaolo Merlini MD

Pages: 1239-1251

Published online: 08 Jul 2014

AbstractforAn overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis | Full Text | References | PDF (471.2 KB)

718 Views
42 CrossRef citations
0Altmetric

Review Article

AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation

Jiun-Tsai Lin PhD, Han-Min Chen PhD, Chih-Hsien Chiu PhD & Yao-Jen Liang PhD

Pages: 1253-1265

Published online: 26 May 2014

AbstractforAMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation | Full Text | References | PDF (1.9 MB)

585 Views
16 CrossRef citations
0Altmetric

Review Article

PDE inhibitors currently in early clinical trials for the treatment of asthma

Maria Gabriella Matera, Clive Page & Mario Cazzola

Pages: 1267-1275

Published online: 28 May 2014

AbstractforPDE inhibitors currently in early clinical trials for the treatment of asthma | Full Text | References | PDF (236.9 KB)

710 Views
33 CrossRef citations
0Altmetric

Drug Evaluations

Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?

Kalliopi Pafili, Nikolaos Papanas & Efstratios Maltezos

Pages: 1277-1284

Published online: 31 Jul 2014

AbstractforGevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases? | Full Text | References | PDF (342.9 KB)

199 Views
9 CrossRef citations
0Altmetric

Atacicept as an investigated therapy for rheumatoid arthritis

Christophe Richez, Marie-Elise Truchetet, Thierry Schaeverbeke & Bernard Bannwarth

Pages: 1285-1294

Published online: 31 Jul 2014

AbstractforAtacicept as an investigated therapy for rheumatoid arthritis | Full Text | References | PDF (375.3 KB)

339 Views
20 CrossRef citations
0Altmetric

Vandetanib as a potential treatment for breast cancer

Antonella De Luca, Amelia D’Alessio, Monica Rosaria Maiello, Marianna Gallo, Simona Bevilacqua, Daniela Frezzetti, Alessandro Morabito, Francesco Perrone & Nicola Normanno

Pages: 1295-1303

Published online: 04 Aug 2014

AbstractforVandetanib as a potential treatment for breast cancer | Full Text | References | PDF (279.6 KB)

293 Views
9 CrossRef citations
0Altmetric

Dinaciclib for the treatment of breast cancer

Carmen Criscitiello, Giulia Viale, Angela Esposito & Giuseppe Curigliano MD PhD

Pages: 1305-1312

Published online: 08 Aug 2014

AbstractforDinaciclib for the treatment of breast cancer | Full Text | References | PDF (348.2 KB)

558 Views
39 CrossRef citations
0Altmetric

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 21 Jun 2024

Free Access

Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs

Lorenza Magagnoli et al.

Review Article | Published online: 19 Jun 2024

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

Luca Iorio et al.

Report | Published online: 16 Jun 2024

Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study

Ling Yang et al.

Article | Published online: 3 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.23, Iss.9, 2014)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?